Actuate Therapeutics Inc (ACTU) vs P3 Health Partners Inc. (PIII)
A side-by-side comparison of Actuate Therapeutics Inc and P3 Health Partners Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACTU
Actuate Therapeutics Inc
$0.80HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
PIII
P3 Health Partners Inc.
$5.70HealthcareDelayed quote: Oct 6, 2026, 3:15 PM EDT
Total return — ACTU vs PIII
growth of $100 · dividends reinvested · last 2yACTU -89.8% (-68.1%/yr)PIII -79.5% (-54.8%/yr)PIII compounded faster over this window
ACTU PIII
ACTU vs PIII: by the numbers
- •ACTU is the larger company ($19M vs $19M market cap).
- •Both run net losses; ACTU's is the smaller (0.00% vs -6.55% net margin).
Metrics side by side
Valuation
| Metric | ACTU | PIII |
|---|---|---|
| P/S ratio | N/A | 0.01 |
| P/B ratio | 19.37 | N/A |
Profitability
| Metric | ACTU | PIII |
|---|---|---|
| Gross margin | 0.00% | -9.89% |
| Operating margin | 0.00% | -18.53% |
| Net margin | 0.00% | -6.55% |
| ROE | -2067.81% | -136.36% |
| ROIC | -1489.99% | -51.68% |
Growth (annualized)
| Metric | ACTU | PIII |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 22.04% |
| Total return CAGR (5Y) | N/A | -58.41% |
Go deeper
Dig into the metrics
Actuate Therapeutics ROEP3 Health Partners ROEActuate Therapeutics operating marginP3 Health Partners operating marginActuate Therapeutics revenue growthP3 Health Partners revenue growthActuate Therapeutics free cash flowP3 Health Partners free cash flow
Actuate Therapeutics & P3 Health Partners appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.